NEOGENOMICS INC — Director's Dealing 2020

Nov 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-11-10

Reporting Person: Pedulla Denise E (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-10	Common Stock	M	15000	$7.85	Acquired	58988	Direct
2020-11-10	Common Stock	S	2262	$42	Disposed	56726	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-10	Stock Option (Right to Buy)	$7.85	M	15000	Disposed	2020-12-08	Common Stock (15000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (25000.0)	25000	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (48334.0)	48334	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (17496.0)	17496	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (18757.0)	18757	Direct

Footnotes

F1: On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vested ratably over the first four anniversary dates of the grant date.

F2: On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F3: On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F5: On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.